Revance Therapeutics, Inc.
2014 Q1 - 2024 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2024 Q4 | 3/18/2025 | 282 | 0.0% | 92,880 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 489 | 0.0% | 94,163 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 250 | 0.0% | 97,324 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 480 | 0.0% | 97,493 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 781 | 0.0% | 88,825 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,063 | 0.0% | 92,675 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 2,570 | 0.0% | 101,534 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 3,296 | 0.0% | 102,316 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 1,897 | 0.0% | 102,748 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 2,642 | 0.0% | 97,856 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,219 | 0.0% | 88,214 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,727 | 0.0% | 88,547 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 1,567 | 0.0% | 96,025 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 2,606 | 0.0% | 93,535 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 2,869 | 0.0% | 96,799 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 2,652 | 0.0% | 94,893 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 2,700 | 0.0% | 95,261 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 2,394 | 0.0% | 95,235 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 2,091 | 0.0% | 85,625 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 1,161 | 0.0% | 78,450 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,114 | 0.0% | 68,618 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 397 | 0.0% | 12,600 | 3/31/2014 |